Healthcare Policy

Healthcare Policy

Here we report a cancer vaccine that induces a coordinated attack by diverse T cell and natural killer (NK) cell populations. 


Medicaid expansion under the Affordable Care Act (ACA) was associated with an increase in 2-year overall survival rates among patients newly diagnosed with cancer...

The ASCO Post

This study examined oncology HCPs perspectives in relation to LGBTQI cancer care, and the implications of HCP perspectives and practices for LGBTQI patients and their caregivers.

Frontiers in Oncology

The US Food and Drug Administration (FDA) has issued three final guidances to industry regarding cancer clinical trials that parallel the goals of President Biden’s recently announced effort...

The ASCO Post

President Biden announced the reigniting of the Cancer Moonshot, with renewed White House leadership of this effort.

The ASCO Post

Friends urges stakeholders in the cancer community to work together to optimize dosing in oncology drug development to maximize benefit for patients and reduce treatment toxicity... 

The ASCO Post

A retrospective analysis of large data sets of biomarkers from tumors and healthy tissue by researchers suggests that older patients with cancer may benefit as much from cancer immunotherapies...

The ASCO Post

The NHS is to recruit tens of thousands of people to take part in a trial of a blood test that aims to detect more than 50 types of cancer before symptoms appear.


In a single-center study, investigators find an overall high level of satisfaction with teleoncology care during the COVID-19 pandemic among veterans with cancer in the US...

The ASCO Post

Kaufman et al find significant decreases in monthly new cancer diagnoses during the first full year of the COVID-19 pandemic compared with the prepandemic period.

The ASCO Post

This is the fourth version of NCCN’s COVID-19 vaccination guide and incorporates the latest data plus recent approvals from the FDA and CDC regarding a third mRNA vaccine dose for immunocompromised

The ASCO Post

An update of the ESMO Clinical Practice Guidelines for NSCLC treatment is provided. 


Genentech announced that it has made the decision to voluntarily withdraw the US accelerated approval for atezolizumab in combination with nab-paclitaxel for the treatment of adults with...

The ASCO Post

In a recent study, researchers analyzed data over a span of 4 years.

The ASCO Post

The FDA is alerting patients and health-care professionals that a clinical trial evaluating melphalan flufenamide with dexamethasone to treat patients with MM showed an increased risk of death...

The ASCO Post

Cancer patients on active treatment had a “pronounced lag” in antibody production after receiving the Pfizer-BioNTech COVID-19 vaccine, researchers reported in JAMA Oncology.

Cancer Therapy Advisor

Among the potential improvements were more efficient study enrollment through secure electronic platforms, direct shipment of oral drugs to patients, remote assessment of adverse events...


A substantial proportion of patients with cancer use PPIs, and up to one-third of these patients are also using oral cancer treatments that could be adversely affected by concomitant PPI use.


New oral antitumor drugs that have been approved since the early 2000s, like kinase inhibitors, have significantly improved outcomes for patients with many types of cancer.

Oncology Times - Latest Articles

A team of researchers developed a new CAR-T cell approach to target a genetic change that commonly occurs in all types of cancer. This genetic alteration, termed LOH, occurs in cancer when...

Oncology Times - Latest Articles

Such testing can identify mutations that may warrant a change of treatment and allow trying a targeted therapy, and it can also guide screening for high-risk individuals and their family members.


The use of palliative care in hospitals in the United States has steadily risen over the past decade, with almost universal access to services in large hospitals and academic medical centers.

The ASCO Post

Results from a Phase I clinical trial suggest that administration of a neoantigen vaccine developed using a computational platform cause no serious safety concerns while...

Oncology Times - Latest Articles

Mooney et al find that an oncology hospital-at-home program reduces unplanned health-care utilization and costs vs usual care among patients with cancer discharged from the hospital.

The ASCO Post

A study investigating the association between state Medicaid income eligibility limits and long-term survival among newly diagnosed patients with cancer has found that patients living in states wit

The ASCO Post

Use of an IRRDC surveillance protocol is associated with improved OS among patients with CMMRD, a cancer predisposition syndrome associated with inheritance of biallelic pathogenic variants in mism

The ASCO Post

The obesity epidemic in the United States may be slowing improvements in cancer mortality, according to a new analysis of over 50 million cancer and heart disease deaths.


This study finds that implementation of an oral CT management program is associated with reduced rates of any-grade and severe capecitabine toxicity, less frequent toxicity-related...

The ASCO Post

For most vitamin and mineral supplements, there is not enough evidence to recommend for or against taking them to prevent cancer and CVD, according to new draft recommendations from the US Preventi


This study examines the safety and immunogenicity of the BNT162b2 vaccine in patients with cancer.

The Lancet Oncology

Emma Copland and colleagues find “no consistent evidence” of an association between antihypertensive treatment and risk for cancer. 

The ASCO Post

African Americans face a higher burden from cancer compared to other racial/ethnic groups in the U.S., and an even greater obstacle to cancer prevention, detection, treatment, and survival.

Oncology Times - Latest Articles

The next 20 years will see a big shift in cancer type rankings, researchers predict.


source list reference

RGB(78, 191, 50)
rgb(171, 222, 222)
rgb(219, 18, 118)
200, 66, 245
rgb(195, 2, 230)
rgb (247, 7, 79)
rgb(14, 133, 237)
rgb(252, 3, 223)
rgb (132, 101, 173)
rgb(209, 15, 15)
rgb(115, 43, 196)
rgb(9, 151, 227)
RGB(171, 29, 196)
rgb(252, 186, 3)
rgb(242, 0, 137)
rgb (247, 7, 79)
rgb(48, 38, 189)
rgb(231, 165, 240)
rgb(230, 21, 49)
rgb (132, 101, 173)
rgb (252, 186, 3)
rgb(156, 242, 7)
rgb(91, 128, 189)
rgb(247, 139, 109)
rgb (132, 101, 173)
rgb(181, 112, 164)
rgb(224, 4, 129)
rgb(20, 13, 222)
rgb(84, 54, 94)
rgb(80, 147, 199)
rgb(117, 2, 247)
rgb(153, 146, 129)
rgb(11, 160, 224)
rgb(245, 111, 66)
rgb (245, 152, 2)
rgb(164, 116, 173)
rgb(219, 105, 96)
rgb(11, 160, 224)
rgb(66, 135, 245)
rgb(101, 11, 212)
rgb(169, 196, 201)
rgb(125, 127, 130)
rgb(5, 235, 235)
rgb(235, 190, 9)
rgb(209, 227, 11)
200, 66, 245
rgb (191, 171, 145)
rgb(126, 14, 237)
rbg(167, 124, 235)
rgb (132, 101, 173)
rgb((217, 11, 193)
rbg(16, 162, 230)
rgb(110, 57, 65)
rgb(217, 7, 192)
rgb (247, 7, 79)
rgb(107, 129, 201)
rgb (214, 104, 96)
rgb(224, 224, 4)
rgb(2, 230, 230)
rgb(186, 130, 237)
rgb(235, 64, 52)
rgb(214, 139, 202)
rgb (132, 101, 173)
rgb(10, 191, 137)